-
PANoptosis: Cross-Talk Among Apoptosis, Necroptosis, and Pyroptosis in Neurological Disorders
19 Jun 2025 17:34 GMT
… into the precise treatment of neurological diseases.Keywords: PANoptosis … in various neurological disease models.73– … remarkable potential in treating neurological disorders. For example, … mechanisms, advancing drug development, and expanding clinical …
-
Experts finally find treatment for incurable viral infection suffered by 122million Americans
19 Jun 2025 18:58 GMT
… concerned as drug-resistant strains are developing, which could … found drugs typically used in cancer treatment may … lips. While antiviral medications can treat symptoms, there is … used to treat multiple sclerosis, a progressive neurological disorder that …
-
Mitochondria and autism: Science unlocks the power within cells for new breakthrough treatments
19 Jun 2025 10:48 GMT
… treatments
Mitochondrial dysfunction is common in autism and may contribute to developmental … focus.
Personalized treatments: Given the … based compounds to treat neurological disorders. Recent studies … effects than conventional pharmaceuticals.
Resveratrol, a …
-
Pharmaceutical Lipid-Based Excipients Market Report 2025 – Strategic Insights For Companies Seeking Expansion, Growth
19 Jun 2025 09:11 GMT
… water-soluble drugs, expansion of … treatments. This was evidenced by the Food and Drug Administration FDA … : Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic … Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing …
-
Global Lennox-Gastaut Syndrome Drug Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
19 Jun 2025 06:56 GMT
… drug market going forward. Pediatric epilepsy, a neurological disorder … medication crucial for managing intractable seizures and preventing developmental … Pharmaceuticals Plc, Ultragenyx Pharmaceutical Inc., Marinus Pharmaceuticals … of treatments for this …
-
Neuren Pharmaceuticals (ASX:NEU) Shows Strong Metrics Despite Market Pullback | ASX 300
19 Jun 2025 05:33 GMT
… company's focus on neurological disorder treatments places it within a specialised … management.
Profit Retention Supports Scalable Development
Neuren Pharmaceuticals does not currently offer any …
-
PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications
18 Jun 2025 12:00 GMT
… neurological disorders, and medical countermeasures. Granted FDA Orphan Drug Designations: Furthermore, the FDA … has granted five orphan drug designations to PharmaTher … treatment, … pharmaceutical development …
-
Team at Miami Transplant Institute give young girl a second chance at life after a rare neurological disease led to kidney failure
18 Jun 2025 02:19 GMT
At just two years old, Emory Crosdale was diagnosed with joubert syndrome, a rare disease that affects how the brain develops, specifically motor skills, balance, and coordination. Some children with the disease might also suffer from kidney and liver …
-
Geriatric Medicines Market Growing Elderly Population and Advancements in Specialized Drug Development Poised to Drive Market Expansion to USD 1,701.91 Billion by 2032
18 Jun 2025 14:04 GMT
… of pharmaceutical companies on developing specialized treatments for … require multiple medications for comorbid conditions … demand for combination drugs and deprescribing strategies …
Respiratory Disorders
Neurological Disorders
Metabolic Disorders
Others …
-
Global Drug Delivery Devices Market | Growth Trends, Top Companies & Future Forecast 2025 | DataM Intelligence
18 Jun 2025 12:45 GMT
… for accurately delivering drugs and enhancing treatment outcomes. Advanced … by pharmaceutical companies is supporting the development of … Drug Delivery Devices
Others.
By Application:
Cancer
Respiratory Diseases
Pain Management
Neurological Disorders …